CME250117C115000
- 110.60
- 0.000.00%
CME Group Newsroom
KBW Maintains CME Group(CME.US) With Hold Rating, Raises Target Price to $260
TD Cowen Maintains CME Group(CME.US) With Hold Rating, Raises Target Price to $257
Keefe, Bruyette & Woods Maintains Market Perform on CME Gr, Raises Price Target to $260
CME Gr Analyst Ratings
Low-Volatility Funds From Vanguard and Others Sound Ideal for This Market. Why They Might Not Be.
TD Cowen Adjusts Price Target on CME Group to $257 From $239
FLACK GLOBAL METALS EXECUTES FIRST BUSHELING FUTURES CONTRACT
SA Sentiment: All-day Stock Trading May Be Inevitable, but Keep the Risks in Mind
10 Financials Stocks With Whale Alerts In Today's Session
U.S. stock market early session | The three major Indexes weakened slightly, while Tesla, Google, and Apple rose against the trend, with stock prices reaching all-time highs; Quantum Concept stocks continue to soar, with QUBT rising nearly 30%.
The market is waiting for the USA Federal Reserve's last monetary policy decision of the year. Retail sales in the USA in November exceeded expectations.
Looking Into CME Gr's Recent Short Interest
Palantir, MicroStrategy Could Be Added to Nasdaq 100 Friday. Moderna, Super Micro Could Be Dropped.
4 ETF Areas Hit One-Year High Amid In-Line November Inflation
KBW Maintains CME Group(CME.US) With Hold Rating, Raises Target Price to $237
Barclays Maintains CME Group(CME.US) With Hold Rating, Maintains Target Price $257
Barclays Reaffirms Their Hold Rating on CME Group (CME)
Zacks Industry Outlook Intercontinental Exchange, CME Group, Nasdaq, Cboe Global Markets and MarketAxess
CME Group Updates Clearing House Fee Schedule
MicroStrategy Stock Could Get Added to the Nasdaq 100 Because of a Quirk
Express News | CME Group Inc : BofA Global Research Raises Price Objective to $192 From $181